Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China flag China · Delayed Price · Currency is CNY
5.20
+0.05 (0.97%)
Feb 3, 2026, 3:04 PM CST

SHE:000597 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
4,0844,4685,6513,8452,5501,481
Cash & Short-Term Investments
4,1004,4685,6513,8452,5501,481
Cash Growth
-19.25%-20.93%46.98%50.76%72.18%-2.89%
Accounts Receivable
2,6722,4942,4042,5392,3762,240
Other Receivables
204.69192.51191.25195.93392.21421.06
Receivables
2,8762,6872,5962,7352,7682,661
Inventory
1,1381,3241,3641,2201,2471,253
Prepaid Expenses
-0.631.172.8616.6411.66
Other Current Assets
113.69166.73171.05127.39216.56145.66
Total Current Assets
8,2288,6469,7837,9316,7995,553
Property, Plant & Equipment
3,7234,0644,4774,8525,2265,489
Long-Term Investments
6.136.13----
Goodwill
153.58154.4526.1226.1226.1226.12
Other Intangible Assets
645.29687.83681.77706.96651.76683.04
Long-Term Deferred Tax Assets
123.69131.38128.07109.29102.0988.99
Long-Term Deferred Charges
755.92742.05143.47122.36302.5262.94
Other Long-Term Assets
12.8413.9734.4762.6671.3462.91
Total Assets
13,64914,44615,27413,81013,18012,166
Accounts Payable
4,0254,8415,7784,3203,6962,764
Accrued Expenses
2.66853.78744.07701.69561.28396.14
Short-Term Debt
1,6791,5421,2901,8822,0502,400
Current Portion of Long-Term Debt
--68842200-
Current Portion of Leases
-20.2323.5217.5820.21-
Current Income Taxes Payable
40.4146.2255.58104.5828.2739.62
Current Unearned Revenue
61.32104.81131.17192.72127.78119.39
Other Current Liabilities
1,573849.18858.071,1621,5151,597
Total Current Liabilities
7,3828,2579,5688,4238,1997,316
Long-Term Debt
165.6-150238200200
Long-Term Leases
17.3830.1431.2917.9417.97-
Long-Term Unearned Revenue
130.03140.91157.12174.72194.05213.32
Long-Term Deferred Tax Liabilities
94.8195.745.225.325.425.56
Other Long-Term Liabilities
261.98352.83202.8238273.2308.4
Total Liabilities
8,0518,87710,1159,0978,8898,043
Common Stock
1,4271,4291,4291,4341,3481,351
Additional Paid-In Capital
2,4872,4902,4682,3752,1462,188
Retained Earnings
1,4911,4611,194978.13646.81558.57
Treasury Stock
-49.27-67.13-110.72-234.78--117.2
Comprehensive Income & Other
8.378.978.417.172.650.99
Total Common Equity
5,3645,3224,9884,5594,1443,981
Minority Interest
233.43248.03170.47153.95146.54141.6
Shareholders' Equity
5,5975,5705,1594,7134,2904,122
Total Liabilities & Equity
13,64914,44615,27413,81013,18012,166
Total Debt
1,8621,5932,1832,1982,4882,600
Net Cash (Debt)
2,2382,8763,4681,64762.17-1,119
Net Cash Growth
-23.77%-17.08%110.51%2549.68%--
Net Cash Per Share
1.582.032.421.180.04-0.91
Filing Date Shares Outstanding
1,4271,4291,4291,4341,3481,351
Total Common Shares Outstanding
1,4271,4291,4291,4341,3481,351
Working Capital
846.62389.56214.57-492.6-1,399-1,763
Book Value Per Share
3.763.723.493.183.072.95
Tangible Book Value
4,5654,4794,2803,8263,4663,271
Tangible Book Value Per Share
3.203.133.002.672.572.42
Buildings
-3,1233,1013,0112,9652,791
Machinery
-5,1775,0474,8084,6064,627
Construction In Progress
-155.48198.87421.64678.41733.22
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.